BEQUENVO
LIVE

Serial Number

79318609

Owner

Sandoz AG

Filing Date

Apr 21, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BEQUENVO Trademark

Serial Number: 79318609 • Registration: 6617421

BEQUENVO is a trademark filed by Sandoz AG on April 21, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Sandoz AG (9 trademarks)

Viaduktstrasse 3

Entity Type: 03

Novartis AG (17 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

April 21, 2021

Registration Date

January 18, 2022

Published for Opposition

November 2, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 3, 2026 NREP
CHANGE OF OWNER RECEIVED FROM IB
Jan 19, 2024 CHLD
NOTIFICATION PROCESSED BY IB
Jun 5, 2022 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 16, 2022 FICS
FINAL DISPOSITION PROCESSED
May 16, 2022 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Feb 17, 2022 GPAR
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2022 R.PR
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTICE OF PUBLICATION
Oct 13, 2021 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2021 CNSA
ASSIGNED TO EXAMINER
Sep 29, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 7, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 30, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 26, 2021 REPR